In addition, Wang et al. [33] recently showed that CD82-positive EVs levels in serum of breast cancer patients are significantly higher than in healthy controls, and that CD82 expression increases significantly with the progression of malignant breast cancer. This evidence concerns the gene CD82 and breast carcinoma.